SecBot SecBot
EFFECT ·Filed Aug 24, 2026

CARL

CARLSMED, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago SEC9999999995-26-002735
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any subsequent prospectus supplement or takedown notice under the shelf. The effective shelf gives management flexibility to raise capital opportunistically, which could pressure the stock if executed at current levels. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
CARL ▼ -2.41% at T+20d
NEUTRAL call -2.41% · α vs SPY -3.72% · entry $15.80 → $15.42
Next anchor: T+60d in 21d
Latest observation: T+43 -18.28% FF3 residual α
Entry = T+0 close
Aug 24, 2026
via day close
T+1d
+1.71%
call +1.71% · α +1.39%
$16.07
settled 2mo ago
T+5d
+3.10%
call +3.10% · α +2.63%
$16.29
settled 8w ago
T+20d
-2.41%
call -2.41% · α -3.72%
$15.42
settled 5w ago
T+60d
Pending
in 21d

Price Chart

Loading chart...

Executive Summary

Carlsmed's S-3 shelf registration (File No. 333-298345) became effective on August 21, 2026, allowing the company to offer and sell securities from time to time. This creates a potential dilution overhang for common stock holders, though no immediate offering has been announced. The shelf registration is a routine capital-raising tool for a $438M market cap medical device company, but the timing and market conditions will determine actual dilution risk.

Key Facts

  • S-3 shelf registration became effective on August 21, 2026
  • File No. 333-298345 under the Securities Act of 1933
  • Company can now offer and sell securities on a delayed or continuous basis
  • No specific offering size, price, or timing disclosed in the EFFECT notice

Financial Impact

No offering terms disclosed; potential future dilution from shelf takedowns

dilution

Risk Factors

  • Potential dilution from future shelf takedowns
  • No disclosure of intended use of proceeds or offering size

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002735
Document: 9999999995-26-002735-index.html9999999995-26-002735
Document: 9999999995-26-002735.txt9999999995-26-002735
6 reports for CARL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CARL — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
144
NEUTRAL ★ 2/10
$13.85awaiting T+20—$14.91 (+7.65%)
Sep 30, 2026
26d ago
8-K
NEUTRAL ★ 4/10
$14.07awaiting T+20—$14.91 (+5.97%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 4/10
$14.18 $14.91▲ +5.15%▲ +5.18%$14.91 (+5.15%)
Sep 15, 2026
5w ago
Insider Buy
BULLISH ★ 6/10
$15.31 $14.47▼ −5.49%▼ −8.66%$14.91 (−2.61%)
Aug 24, 2026
9w ago
EFFECT
NEUTRAL ★ 3/10
$15.80 $15.42▼ −2.41%▼ −3.72%$14.91 (−5.63%)
Jul 22, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$11.00 $16.50▲ +50.00%▲ +46.69%$14.91 (+35.55%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 8h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 24, 2026